StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$12.75−0.40 (-3.04%)

Close on Nov 16, 2026Market cap $86.56MP/E –Yield –

Eloxx Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Eloxx Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2012 was -2705.8%. For fiscal 2024 it was -38.8%, against -5019.9% the year before. The highest annual figure on record is -38.8% in fiscal 2024.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-38.8%+4981.1
FY2014Jun 30, 2014-5019.9%+54457.0
FY2013Jun 30, 2013-59476.9%−56771.2
FY2012Jun 30, 2012-2705.8%+756.0
FY2010Jun 30, 2010-3461.8%–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?